Compare AORT & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AORT | MMI |
|---|---|---|
| Founded | 1984 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.2B |
| IPO Year | 1993 | 2013 |
| Metric | AORT | MMI |
|---|---|---|
| Price | $44.94 | $27.82 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $49.36 | $29.00 |
| AVG Volume (30 Days) | 346.5K | ★ 364.5K |
| Earning Date | 11-06-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $422,646,000.00 | ★ $751,284,000.00 |
| Revenue This Year | $15.97 | $11.94 |
| Revenue Next Year | $10.96 | $15.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 9.81 | ★ 20.74 |
| 52 Week Low | $21.97 | $27.35 |
| 52 Week High | $48.04 | $41.94 |
| Indicator | AORT | MMI |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 36.79 |
| Support Level | $42.68 | $28.74 |
| Resistance Level | $46.02 | $29.65 |
| Average True Range (ATR) | 1.35 | 0.82 |
| MACD | -0.18 | -0.13 |
| Stochastic Oscillator | 53.39 | 13.28 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.